Cogent Biosciences COGT
NASDAQ COGT
$34.76 -0.19 (-0.54%)
As of: Sep 4, 2026 · 3:59 PM EDT

Cogent Biosciences (COGT) FCF Margin Growth (1y) (2018 - 2020)

Analysis

Cogent Biosciences (COGT) FCF Margin Growth (1y) (2018 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -89.00
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -1,183.00
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 26,102.00
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 869.00
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 769.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - 811.00
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 19,111.00
10 Cogent Biosciences 5.94 Bn 5.94 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 -229,218.00
Jun 30, 2020 -121,501.00
Mar 31, 2020 26,638.00
Dec 31, 2019 18,173.00
Sep 30, 2019 -62,354.00
Jun 30, 2019 13,477.00
Mar 31, 2019 -1,427.00
Dec 31, 2018 7,458.00
Sep 30, 2018 -9,335.00
Jun 30, 2018 -20,874.00
Mar 31, 2018 5,096.00